EMBEDA 20 (Embeda morphine 20 mg / naltrexone 0.8 mg)
Generic Name: morphine/naltrexone
Pill with imprint EMBEDA 20 is Yellow, Capsule-shape and has been identified as Embeda morphine 20 mg / naltrexone 0.8 mg. It is supplied by Pfizer Inc.
Embeda is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Embeda morphine 20 mg / naltrexone 0.8 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for EMBEDA 20
Embeda
- Generic Name
- morphine/naltrexone
- Imprint
- EMBEDA 20
- Strength
- morphine 20 mg / naltrexone 0.8 mg
- Color
- Yellow
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Narcotic analgesic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Pfizer Inc
- National Drug Code (NDC)
- 60793-0430 (Discontinued)
- Inactive Ingredients
-
magnesium silicate,
sodium chloride,
dibutyl sebacate,
diethyl phthalate,
magnesium stearate,
sodium lauryl sulfate,
ascorbic acid,
titanium dioxide,
D&C Yellow No. 10,
ammonio methacrylate copolymer type B,
methacrylic acid - ethyl acrylate copolymer (1:1) type a
Note: Inactive ingredients may vary.
More about Embeda (morphine / naltrexone)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (49)
- Drug images
- Drug class: narcotic analgesic combinations
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.